Purpose of the Test
- Differentiate between Type 1, Type 2, and monogenic MODY diabetes.
- Identify specific genetic mutations including HNF1A, HNF4A, and GCK.
- Guide physicians in selecting oral medications over insulin when appropriate.
Are you a young, non-obese individual with diabetes? The MODY screen identifies genetic mutations like HNF1A and GCK, enabling a precise diagnosis and a personalized treatment plan tailored to your genetic profile.
Scientific name: Maturity-Onset Diabetes of the Young (MODY) Screen
Advanced genetic testing targeting HNF1A, HNF4A, and GCK mutations. Ideal for non-obese patients diagnosed with diabetes before age 25, ensuring accurate classification of MODY and optimized therapeutic management.